Kristen Ullman

Papers

Total Citations

H-Index

About

Kristen Ullman’s research centers on evidence-based medicine and systematic review methodology, with a particular focus on prostate cancer treatment outcomes. Her major contribution lies in synthesizing complex clinical data to inform treatment guidelines for clinically localized prostate cancer (CLPC). In her landmark 2020 work, funded by the Agency for Healthcare Research and Quality and the American Urological Association, Ullman led an exhaustive update of therapeutic evaluations for CLPC, analyzing literature from 2013 through January 2020 alongside ClinicalTrials.gov registries. This comprehensive review has become a critical resource for urologists and oncologists navigating treatment decisions, earning 2 citations to date. Beyond this flagship paper, Ullman’s expertise in systematic review design has shaped how comparative effectiveness research is conducted in oncology. Her work exemplifies the rigorous, transparent synthesis of evidence needed to bridge research and clinical practice. For students and researchers, Ullman demonstrates how meticulous literature analysis can directly impact patient care standards, making her a key figure in the advancement of urological evidence-based medicine.